Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

8
How Amazon Is Creating Amazing Dividend Aristocrat Buying Opportunities

10h seekingalpha
Fears over the Amazon effect in healthcare are real but in the case of these two stocks, we see it as overdone.
WBA CAH

18
Is Johnson & Johnson Worth Another Look After Its Earnings Victory?

10h investorplace
Ahead of its all-important second-quarter fiscal 2018 earnings report, Johnson & Johnson (NYSE:JNJ) finds itself in an unenviable situation. On a year-to-date framework, JNJ is one of the worst companies in the Dow Jones Industrial Average, shedding nearly 11%. Only four other companies have worse performances. So will the JNJ earnings report turn things around or is 2018 not salvageable?
PG JNJ WBA NYTAB WMT MMM

47
Buying Dividend Growth Stocks Without Looking - More Than 3 Years Later.

13h seekingalpha
The companies were purchased for their collective potential to deliver very solid total returns, but offering less volatility through a major market correction.
ABT LOW TXN WBA UTX CVS WMT MDT NKE JNJ CL MSFT QCOM MMM

48
4 Underappreciated Stocks to Buy Before the Analysts Weigh In | InvestorPlace

13h investorplace
In order to make money as a value investor, you’ve got to be willing to go against the grain and buy when the market has turned its back on a particular company. Bargain hunting on Wall Street can be a tricky business, as it is difficult to find up-and-coming stocks without the help of glowing anaylsts’ reports. However, if you’re buying after the analysts weigh in, you’ve likely already missed a huge wave of momentum.
IBM MPW WBA MS.PRE MS.PRF MS.PRG MS.PRA WMT AMZN MS.PRI MS.PRK SBUX MS

58
Stock Market News For Jul 16, 2017

2018-07-16 zacks
Markets closed higher on Friday, with the S&P 500 posting its highest close in more than five months. The Dow too reclaimed its 25,000 mark for the first time in almost a month. The rally was led by tech and industrial stocks, which offset a decline in financial stocks, as results from three of the major banks failed to boost investors’ confidence.
WFCNP FB MTSI C.WSA CAT WBA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ AMZN WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C CATR C.PRL C.PRJ C.PRK UTX C.PRG C.PRC GTT C.PRPCL CGBBW MSFT

5
Selling Premium On Cisco And Arista

2018-07-16 seekingalpha
This news sent competitors in this sector such as Cisco Systems, Arista Networks and Juniper Networks crashing.
ANET JNPR WBA CSCO

165
Amazon Hastens Retail Pharma's Last Stand

2018-07-15 seekingalpha
Amazon continues to startle markets with its market performance to date, leaping almost 52% through Friday's market close.
BRK.A ABC KR RAD WBA DTK CI CVS AET WMT ESRX

13
US stocks edge higher as Nasdaq ekes out record

2018-07-13 channelnewsasia
NEW YORK: Wall Street stocks finished modestly higher on Friday (Jul 13), with the Nasdaq eking out a second straight record as beaten-down consumer stocks rallied.
WFC WFCNP WFC.WS WFC.PRL COST WBA WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

7
S&P 500 hits 4-month high as Amazon shares rise

2018-07-13 cnbc
The S&P 500 posted on Friday its best closing level since early February as shares from some of the largest tech companies hit record highs.
WFC WFCNP WFC.WS WFC.PRL WBA WFC.PRJ UTX WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

23
Walgreens, United Technologies Boost the Dow Friday

2018-07-13 247wallst
July 13, 2018: Markets opened slightly higher Friday, dipped lower soon after the opening bell, and then traded mostly in the green for the rest of the day. The Nasdaq Composite traded right on the break-even line for much of the afternoon. Industrials, energy, and consumer staples were the day’s leading sectors while telecom and financials lagged. Three big banks—Citi, Wells Fargo, and JPMorgan—reported second-quarter results this morning to no boisterous reception.
WFC WFCNP WFC.WS WBA WFC.PRL WFC.PRJ UTX WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN BOE WFC.PRY BA WFC.PRX WFC.PRW DIS WFC.PRV

143
Buy Walgreens (WBA) Stock Because It's Cheap & Amazon Fears Are Overblown?

2018-07-12 zacks
Shares of Walgreens Boots Alliance (WBA - Free Report) are down 16.5% over the last year based mostly on Amazon (AMZN - Free Report) fears. There is no doubt that online selling and delivery have altered the retail world, but does that mean Walgreens can no longer compete? Let’s dive into some of WBA’s fundamentals to see what to do with the stock.
TGT RAD WBA WMT

58
Top 10 Of 53 Dividend Aristocrats Yield 3.4%-6.2% In July Update

2018-07-11 seekingalpha
The 53 Aristocrats stocks represent all 11 Morningstar sectors. Broker target top 10 net gains ranged from 12.8% to 20.6%.
APD XOM WBA KMB PEP JNJ CVX DOV ABBV CAH ED ABBV MCD

12
After Feuding With Drug Middlemen, Startup Fields a Competitor - Bloomberg

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WBA CVS

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

21h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

23h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to WBA / Walgreens Boots Alliance, Inc. on message board site Silicon Investor.

Walgreen Boots Alliance - WBA Snowball.com, Inc. (Nasdaq - SNOW)
CUSIP: 931427108